BioNano Genomics DIO Ratio 2011-2026 | BNGO

Annual DIO Ratio BioNano Genomics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
251	245	394	352	203	211	186	44.8	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
394	44.8	236

Quarterly DIO Ratio BioNano Genomics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
214	304	320	-	124	413	394	-	458	471	537	-	211	143	270	-	181	150	136	-	207	502	360	186	132	202	180	32.6	31.8	53.8	150	103	45.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
537	31.8	233

DIO Ratio of other stocks in the Diagnostics research industry

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	25.4	-	-6.23 %	$ 30.6 M	Germany
Bioventus BVS	177	$ 9.26	1.09 %	$ 617 M	USA
DarioHealth Corp. DRIO	171	$ 8.45	9.74 %	$ 33.7 M	Israel
DexCom DXCM	115	$ 66.09	-1.12 %	$ 25.8 B	USA
Enzo Biochem ENZ	156	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	60.9	-	-	$ 19.8 B	USA
Heska Corporation HSKA	137	-	-	$ 1.31 B	USA
Oxford Immunotec Global PLC OXFD	210	-	-	$ 562 M	Britain
ICON Public Limited Company ICLR	0.213	$ 103.08	3.09 %	$ 8.5 B	Irlanda
IDEXX Laboratories IDXX	84.3	$ 573.29	-0.42 %	$ 46.1 B	USA
Illumina ILMN	137	$ 124.4	-1.43 %	$ 19.8 B	USA
DermTech DMTK	33.5	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	23.1	-	-6.19 %	$ 10.5 M	USA
Co-Diagnostics CODX	304	$ 4.4	101.83 %	$ 129 M	USA
Accelerate Diagnostics AXDX	198	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	89.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	131	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	42.1	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	62.8	-	0.12 %	$ 80.1 M	China
Myriad Genetics MYGN	42.8	$ 4.62	-1.28 %	$ 428 M	USA
HTG Molecular Diagnostics HTGM	116	-	-20.0 %	$ 1.06 M	USA
Natera NTRA	25.8	$ 196.15	-0.62 %	$ 19.3 B	USA
Charles River Laboratories International CRL	35.3	$ 165.13	-0.46 %	$ 8.18 B	USA
Organovo Holdings ONVO	371	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	459	-	-16.95 %	$ 1.54 M	USA
OPKO Health OPK	45.2	$ 1.17	-1.68 %	$ 812 M	USA
Pacific Biosciences of California PACB	173	$ 1.35	-2.88 %	$ 405 M	USA
Biocept BIOC	21.9	-	-13.05 %	$ 7.29 M	USA
ENDRA Life Sciences NDRA	405	$ 4.59	22.4 %	$ 2.46 M	USA
PerkinElmer PKI	87.6	-	-0.91 %	$ 14.7 B	USA
Invitae Corporation NVTA	126	-	-	$ 21.2 M	USA
Personalis PSNL	12.1	$ 7.32	-4.94 %	$ 434 M	USA
Interpace Biosciences IDXG	26.2	$ 1.73	2.37 %	$ 7.59 M	USA
Motus GI Holdings MOTS	3.37 K	-	-34.28 %	$ 263 K	Israel
QIAGEN N.V. QGEN	141	-	-	$ 10.6 B	Niderland
Chembio Diagnostics CEMI	97.6	-	0.22 %	$ 16.8 M	USA
Senseonics Holdings SENS	104	$ 6.56	-2.96 %	$ 274 M	USA
Laboratory Corporation of America Holdings LH	18.9	$ 268.38	0.89 %	$ 22.3 B	USA
NeoGenomics NEO	24.4	$ 7.76	-0.13 %	$ 994 M	USA
Soleno Therapeutics SLNO	1.02 K	$ 31.83	-0.03 %	$ 1.62 B	USA
Precipio PRPO	21.7	$ 27.2	-0.15 %	$ 35.3 M	USA